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The Editor welcomes submissions for
possible publication in the Letters to the
Editor section that consist of commen-
tary on an article published in the Jour-
nal or other relevant issues. Authors
should:
● Include no more than 500 words of text,
three authors, and five references
● Type with double-spacing
● See http://jtcs.ctsnetjournals.org/misc/
ifora.shtml for detailed submission
instructions.
● Submit the letter electronically via
jtcvs.editorialmanager.com.
Letters commenting on an article pub-
lished in the JTCVS will be considered if
they are received within 6 weeks of the
time the article was published. Authors
of the article being commented on will be
given an opportunity to offer a timely
response (2 weeks) to the letter. Authors
of letters will be notified that the letter
has been received. Unpublished letters
cannot be returned.
Thmall aortic annulus: The
ydrodynamic performances of 5
ommercially available tissue valves
o the Editor:
e are writing to comment on the study by
erosa and associates1 published in a re-
ent issue of the Journal.
This highly interesting report compared
eometric dimensions and hemodynamic
erformance of 5 different stented tissue
alves for aortic valve replacement. Three
ericardial bioprostheses (Carpentier-
dwards Perimount Magna [Edwards Life-
ciences, Irvine, Calif], Sorin Soprano, and
orin Mitroflow [Sorin Biomedica Spa, Sa-
uggio, Italy]) and 2 porcine bioprostheses
Medtronic Mosaic [Medtronic, Inc, Min-
eapolis, Minn] and St Jude Medical Epic
upra [St Jude Medical, Inc, St Paul,
inn]) were tested at cardiac outputs of 2,
, 5, and 7 L/min. So that a meaningful
omparison could be made, prostheses that
ould be fitted in a 21-mm pulse duplicator
ing were used, regardless of industry-
abeled valve size. This addresses a very
mportant issue that we try to solve for in
ivo comparisons of different valve types
y calculating the “effective orifice frac-
ion,” which is the ratio of the intraopera-
ively measured aortic annulus area and the
chocardiographically obtained effective
rifice area of the prosthesis.2,3
In our opinion, one of the most striking
esults of the study by Gerosa’s group was
he finding that even some of the geometric
imensions given by the manufacturers
ould not be reproduced by direct measure-
ents, such as the internal or the tissue
nnulus diameter of certain bioprostheses.
The authors state that there are some
iscrepant findings compared with in vivo
esults published by our group: We found
hat in some patients the implantation of a
edtronic Mosaic valve labeled one size
igger than the Carpentier-Edwards Peri-
ount valve was possible because of the
maller geometric dimensions of this
alve.4 In the described in vitro setting,
psizing of the Medtronic Mosaic com-
ared with the Carpentier-Edwards Peri-
e Journal of Thoracic and Cardiovascular Sount Magna was not possible. This cor-
esponds to our in vivo findings, because
he Carpentier-Edwards Perimount Magna
as a 3-mm smaller sewing ring diameter
han the Carpentier-Edwards Perimount for
he identical labeled valve size. Thus, the
emodynamic benefit of the Carpentier-
dwards Perimount Magna valve results
rom the possibility of upsizing.5
The second cited manuscript from our
roup3 is a prospective, nonrandomized
omparison of 3 completely supra-annular
rostheses (Carpentier-Edwards Perimount
agna, Medtronic Mosaic, and Sorin So-
rano) with one intrasupra-annular valve
Carpentier-Edwards Perimount). These
gain were in vivo comparisons in which
he sewing ring dimensions and the aortic
oot anatomy played a decisive role in the
election of a certain valve size. The basic
ndings of this work were that in patients
ith an aortic annulus of 18 to 20 mm in
iameter (intraoperative direct measure-
ents with a Hegar dilator), no significant
emodynamic differences between the in-
estigated prostheses were present, whereas
n patients with an annulus diameter between
1 and 23 mm, the Carpentier-Edwards Peri-
ount Magna showed superior hemody-
amic results compared with the other
rostheses because of the beneficial ratio of
ewing ring and internal orifice diameters.
e disagree with the statement of Gerosa’s
roup that these conclusions would clash
ith their in vitro data. In our opinion, the
ecision that leads to the selection of a
ertain valve size in a complex anatomic
tructure, such as the aortic annulus in
ombination with prosthesis dimensions in-
luding stent height, sewing ring diameter,
omplete supra-annular position, and ana-
omic relation to the coronary ostia, is re-
ponsible for the different findings (Figure 1).
Walter B. Eichinger, MD, PhD
Ina M. Hettich, MD
Ruediger Lange, MD, PhD
German Heart Center Munich
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Letters to the Editor
1Walter Eichinger reports lecture fees from Ed-
wards Lifesciences and St Jude Medical. Rue-
diger Lange reports lecture fees from Edwards
Lifesciences and the Sorin Group.
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eply to the Editor:
e appreciate the comments of Eichinger,
ettich, and Lange on our recent article
eporting on in vitro performances of 5
ifferent aortic tissue valves designed for
upra-annular implantation.1
We agree that the complex aortic root
natomy is responsible for different find-
ngs and different prosthesis fittings, be-
ause larger sewing rings and higher pro-
les may play a crucial role in terms of
ncumbrance in the sinus portion of the
orta. We selected the largest prostheses of
ach model that could be fitted in a 21-mm
alve holder regardless of the manufactur-
r’s size. We observed that the valves with
he more advantageous ratio between inter-
al orifice versus tissue annulus–sewing
ing diameters were the Sorin Mitroflow
Sorin Biomedica Spa, Saluggia, Italy) and
he Carpentier-Edwards Magna bioprosthe-
es (Edwards Lifesciences, Irvine, Calif).
nfortunately, the Mitroflow valve has not
hows two aortic root anatomies with an
e bulbar-shaped root. This is the ideal si
ponds to the internal orifice diameter (IOD)
ot. Despite the same TAD, a completely su
r valve (white) has to be chosen with the co
is, stent and sewing ring material impair
plantation of a valve large enough to ens
that hemodynamic benefit cannot be achie
ent of the prosthesis. ESRD, External seween studied by Eichinger, Hettich, and d
ascular Surgery ● December 2006ange. Nevertheless, comparing the hydro-
ynamic performances of the Sorin Soprano
ersus the Carpentier-Edwards Magna, we
id not observe significant differences be-
ween the two valves, such as those observed
y this group in vivo.2 Eichinger’s group
ighlights the beneficial ratio between inter-
al and sewing ring diameters as well
s the hemodynamic performances of the
arpentier-Edwards Magna valve. In vivo,
he beneficial effect was observed only when
omparing patients with a larger tissue annu-
us diameter (between 21 and 23 mm); sur-
risingly, this benefit disappeared for the
maller diameters (18-20 mm). We believe
hat the beneficial ratio between internal ori-
ce diameter and sewing ring diameter is
alid also for 19- or 21-mm prostheses and
ot only for the larger prosthesis sizes. More-
ver, since the upsizing of the Medtronic
osaic (Medtronic, Inc, Minneapolis, Minn)
ersus the Carpentier-Edwards Magna pros-
hesis was not possible in our in vitro study,
e maintain that the hemodynamic benefit,
bserved in vivo with the Carpentier-
dwards prosthesis in comparison with the
edtronic Mosaic by Eichinger and coau-
hors,3 results mostly from the different in-
ernal orifice diameters and tissue annulus
ntical tissue annulus diameter
ion for complete supra-annular
he prosthesis (TAD  IOD). The
-annular valve of the same size
quence that, despite implanting
bloodstream. Thus the shape of
that the IOD corresponds to the
in every aortic root because of
ing diameter.ng s ide
mor tuat
rres of t
c ro pra
alle nse
thes the
e im ure
sis ved
em ing riameters rather than from the prosthesis up-
